Here are the biggest calls on Wall Street This Week:

Melius reiterates Nvidia as buy

Melius says NVIDIA is a SpaceX beneficiary.

“Elon Musk may have just increased Nvidia’s revenue visibility for 2027 and beyond to the upside. On SpaceX’s earnings call, Musk stated that SpaceX has decided to exclusively use Nvidia compute and suggested the company could deploy closer to 8GW of AI compute during 2027.”

Bank of America reiterates SpaceX as buy

The firm said it was pleased with the company’s first public earnings report.

“We acknowledge SpaceX’s (SPCX) strong 2Q print, its first as a public company. SPCX beat expectations across topline and profitability metrics, and we see the company’s reporting and communication as constructive.”

UBS reiterates Apple as neutral

UBS says its checks show flat Apple App Store revenue.

“Our analysis of Sensor Tower data indicates that global App Store revenue was essentially flat FX neutral (FXN) in the month of July, slightly lower than the ~2% growth in June‑26 quarter.”

Deutsche Bank upgrades Palantir to buy from hold

Deutsche Bank calls Palantir Technologies Inc.’s earnings results “exceptional.”

“With an even more‑reasonable valuation following another substantial beat and raise, we are upgrading our rating to Buy from Hold while maintaining our $200 TP.”

Bank of America reiterates Micron as buy

Bank of America says Micron Technology shares are compelling at current levels.

“In our view, MU remains still attractive given: 1) Bear‑case earnings (potentially ~$100+) could still be far above historical peak (~$12); 2) Broadening LTAs [long term agreement] (50‑70%+ of capacity) improve supply/demand visibility, reduce price volatility...”

Stifel reiterates Tesla as buy

Stifel lowered its price target on the stock but is sticking with Tesla Motors shares.

“Importantly, we believe TSLA is making strong progress on FSD and Robotaxi, both critical to value creation, and see a demand resurgence evidenced by its largest order backlog since 2023 and the Model YL launch. We maintain our Buy rating and are lowering our target price to $491 from $508 based on our sum-of-the-parts analysis.”